Medical/Pharmaceuticals
Essence SmartCare Launches VitalOn Remote Patient Monitoring Solution
Leading Connected Homecare Solutions Provider Adds Advanced Health Monitoring
Platform to Existing Senior Care Offering
HERZLIYA, Israel, May 28, 2021 /PRNewswire/ -- Essence SmartCare
2021-05-28 07:00
2456
Viatris Signs Memorandum of Understanding with The Defeat NCD Partnership at the United Nations Institute for Training and Research (UNITAR)
Reveals initial findings of the Viatris sponsored report at a high-level panel discussion GENEVA and DUBAI, United Arab Emirates, May 28, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) and The Defeat-NCD Partnership (DNCD) at The United Nations Institute for Training and Research (UNITAR) toda...
2021-05-28 06:36
9590
MTD Group takes part in the global effort to accelerate the COVID-19 vaccination, thanks to its new Low Dead Space syringes
LUGANO, Switzerland, May 28, 2021 /PRNewswire/ -- In delivering the COVID-19 global vaccination campaign, it is of paramount importance to be able to maximize the number of individuals that can benefit from the available vaccine vials. In particular, the use of low dead space (LDS) syringes can ...
2021-05-28 03:49
2939
SINOMED announces the HT Supreme DES has similar performance as the market-leader across the spectrum of lesion complexity
TIANJIN, China, May 27, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, today announced results from the HT Supreme™ Healing-Targeted Drug-Eluting Stent (DES), in complex patients compared to the Xience or Promus family of DES. One-year results were presented at las...
2021-05-27 22:00
3105
Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis(IPF) shows promising result in early stage clinical test
* We confirmed the safety of 'DWN12088' and secured grounds for establishing treatment dosage * Confirming the potential as a treatment for IPF and planning to apply for Ph.2 within 2021 * 2nd ODD granted as treatment for systemic sclerosis from the US FDA SEOUL, South Korea, May 27, 2021...
2021-05-27 21:00
1870
GenapSys Announces $70 Million in Series D Equity Financing and Expansion of its Board of Directors
REDWOOD CITY, Calif., May 27, 2021 /PRNewswire/ -- GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised$70 million in a Series D equity financing. Investors in the round included Farallon Capital Management, L...
2021-05-27 19:12
3909
CardiacSense's medical watch was handpicked to remotely monitor vital signs and general medical condition of the Israeli Astronaut's vitals while in space
CAESAREA, Israel, May 27, 2021 /PRNewswire/ -- CardiacSense, a Medtech company and the Israel Aerospace Medicine Institute were selected to send CardiacSense's medical watch to space. The clinically verified medical grade watch enables continuous, long-term, medical grade and comfortable patient ...
2021-05-27 18:21
3373
ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company
BERLIN and CAIRO, May 27, 2021 /PRNewswire/ -- ProBioGen and Minapharm Pharmaceuticals announce the incorporation of ProBioGen's subsidiary "MiGenTra" with headquarters inBerlin and access to a site in Cairo, which will house its principal manufacturing plant. The formation of MiGenTra accelerate...
2021-05-27 17:00
2956
Betagenon AB announces new CEO and new Chairman of the Board
STOCKHOLM, May 27, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced that James Hall BM, BCh, D.Phil has joined this month as CEO. Dr. Hall brings extensive senior healthcare and life science experience, including 12 yea...
2021-05-27 15:46
1576
Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision
DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9 fluorescent channels and remarkably improved user experience BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 27, 2021 /PRNewswire/ ...
2021-05-27 15:00
1645
Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision
DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9 fluorescent channels and remarkably improved user experience BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 27, 2021 /PRNewswire/ ...
2021-05-27 15:00
1509
Love Never Stops, Joining hands to care NMOSD patients across Asia and saying "NO" to relapse
BEIJING, May 27, 2021 /PRNewswire/ -- There is such a group of patients, who are at the golden age of their lives and should have been energetic students in the ivory tower, ladies braving the wind and waves in the workplace, or warm wives expecting at home … Their lives were full of hopes and dr...
2021-05-27 14:18
2731
Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer; Accord BioPharma to Head the U.S. Commercialization
TAIPEI, May 26, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for CAMCEVI® 42 mg, a ready-to-use 6-month subcutaneous depot formulation of leuprolide mesylate, as a ...
2021-05-27 11:33
2896
Neteera makes annual CNBC Disruptor 50 list second year running
JERUSALEM, May 27, 2021 /PRNewswire/ -- Neteera
2021-05-27 09:00
2395
Gannex Received China IND Approval of Its FXR Agonist ASC42 for NASH Indication
SHANGHAI, May 27, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces that China National Medical Products Administration (NMP...
2021-05-27 08:30
3572
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership
SHANGHAI and ROCKVILLE, Md., May 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, clinical-stage biopharmaceutical company, today announced that the companies have entered ...
2021-05-27 08:30
6170
Advanced Micro- and Nanofluidics to Revolutionize the Point-of-care Diagnostic Industry
With the COVID-19 outbreak rapidly decentralizing healthcare diagnostics, the use of microfluidics-based point-of-care diagnostic devices can provide higher accuracy, finds Frost & Sullivan SANTA CLARA, Calif., May 27, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Advanced Micro- and ...
2021-05-27 02:59
1629
Inteleos Announces MedGlobal and Global Ultrasound Institute as MissionPOCUS Selection for 2021
ROCKVILLE, Md., May 26, 2021 /PRNewswire/ -- The Point-of-Care Ultrasound (POCUS) Certification Academy under Inteleos announced a pilot project with MedGlobal and the Global Ultrasound Institute as the selection of their MissionPOCUS™ project for 2021. As the fourth MissionPOCUS project since th...
2021-05-26 23:36
1594
Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China
SHANGHAI, May 26, 2021 /PRNewswire/ -- Luye Pharma Group announced today that its holding subsidiary, Boan Biotech, has signed an agreement with AstraZeneca China regarding the promotion rights to the anticancer drugBoyounuo® (Bevacizumab Injection), under which the former will grant to the latte...
2021-05-26 23:03
20672
TransThera announces collaboration with Roche to evaluate TT-00420 as part of a novel combination to treat GI cancers in China
NANJING, China, May 26, 2021 /PRNewswire/ -- TransThera Biosciences Co. Ltd. ( "TransThera" ), a clinical stage biotechnology company dedicated to developing innovative therapeutics across oncology, cardiovascular, and inflammatory diseases with major unmet medical needs globally and inChina, to...
2021-05-26 21:00
1777
Week's Top Stories
Most Reposted
iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 279 media titles]
2026-01-01 10:00
ACEN completes transition to 100% renewable energy
[Picked up by 274 media titles]
2025-12-29 18:53Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 274 media titles]
2025-12-30 20:12
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 264 media titles]
2025-12-29 09:00
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 261 media titles]
2025-12-29 14:27Most Read
China Daily Launches "China Bound" -- An English-Language Smart-Tourism Service Platform for International Travelers
2026-01-01 17:04
7609
